The following awardees have been chosen:
- A Liquid Biopsy ‘hub’: integrating Nano-technologies to improve cancer diagnosis and therapy (Patrizio Giacomini, RCSS National Cancer Institute Regina Elena, Italy)
- Best Open Innovation in Science Practice for the Establishment of Interdisciplinary & Inter-Sectoral Collaboration Platforms for the Implementation of PM (Juergen Busch, Ludwig Boltzmann Gesellschaft, Austria)
- Translating genotype data into clinical pharmacogenetic recommendations: challenges and solutions (Sulev Reisberg, University of Tartu, Estonia)
- Development and integration of organoid models in personalised medicine platforms (Mark A. Rubin, University of Bern, Switzerland)
The four awardees will be invited to the ICPerMed Workshop on 5-6 November 2019 in Madrid and will present their results during a plenary session. They will receive a non-cash award of EUR 500 to support the dissemination of their work. Eight further highly-ranked proposals will be invited to present a poster of their work during the ICPerMed Workshop.
The call for submission of proposals for the ICPerMed "Best Practice in Personalised Medicine" Recognition 2020 will presumably open in November 2019.